Get More Every Week Subscribe to Nanalyze Weekly - our free, no-nonsense newsletter that delivers weekly article summaries, emerging tech insights, and clear analysis on disruptive tech companies - plus our bonus '7 Lessons From 20 Years of Disruptive Tech Investing' guide.
We believe in science, empathy, and transparency
Nat Rev Endocrinol 21 , 521522 (2025)
These injections are integrated into personalized weight loss programs designed to meet each patients unique needs
This approval marked a turning point in obesity medicine, as semaglutide became one of the first GLP-1 receptor agonists developed specifically for weight loss rather than adapted from diabetes treatment
The past month, online retailer iHerb launched a supplements line specifically designed to support customers using semaglutide medications